Get started
Author

Aswath P. Chandrasekar

Observed names: A. Padmanabhan Chandrasekar, Aswath P Chandrasekar
ORCID: 0000-0002-2352-2456
Observed ORCID: 0000-0002-2352-2456
OpenAlex ID: A5081395778
The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence
2019 · Aswath P. Chandrasekar, Nathan W. Cummins, et al. · Clinical Microbiology Reviews · 54
Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2
2020 · Andrea J. French, Sekar Natesampillai, et al. · PLoS Pathogens · 39
PDF
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model
2022 · Aswath P. Chandrasekar, Nathan W. Cummins, et al. · Journal of Virology · 29
Prime, shock and kill: BCL-2 inhibition for HIV cure
2022 · Aswath P. Chandrasekar, Andrew D. Badley · Frontiers in Immunology · 23
PDF
The Combination of Venetoclax and Ixazomib Selectively and Efficiently Kills HIV-Infected Cell Lines but Has Unacceptable Toxicity in Primary Cell Models
2021 · Alecia Alto, Sekar Natesampillai, et al. · Journal of Virology · 19
Dynamic modulation of the non-canonical NF-κB signaling pathway for HIV shock and kill
2024 · Aswath P. Chandrasekar, Mark Maynes, et al. · Frontiers in Cellular and Infection Microbiology · 11
PDF
TRAILshort Protects against CD4 T Cell Death during Acute HIV Infection
2019 · Sekar Natesampillai, Ana C Paim, et al. · The Journal of Immunology · 7
Mucinous cystic neoplasms of the pancreas demonstrate in situ production of estrogen
2025 · Jinyong Kim, Aswath P. Chandrasekar, et al. · Frontiers in Cell and Developmental Biology · 1
PDF
“It’s Pink!”
2024 · Aswath P Chandrasekar, Qian Wang, et al. · Clinical Chemistry · 1
PDF
Increased CAR-T Infusions Occur in Conjunction with Decreased Hematopoietic Stem Cell Transplantation
2023 · Aswath P. Chandrasekar, Richard C. Godby, et al. · Blood · 1
TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo
2026 · Shahrzad Jalali, Sekar Natesampillai, et al. · Journal of Clinical Investigation
What is a CAR-T Cell?
2025 · Aswath P. Chandrasekar · Transfusion Medicine Reviews
Increasing use of CAR‐T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6‐year period: Resource utilization implications
2025 · Aswath P. Chandrasekar, Margret A. DiGuardo, et al. · Transfusion
Improved Preprocedure Hematocrit in Chronic RBC Exchange Patients Following Splenectomy: A Case Report
2025 · Aswath P. Chandrasekar, Scott A. Koepsell, et al. · Case Reports in Hematology
PDF
P‐TS‐95 | Type and Screen Orders From the OR: Can This Practice Be Improved?
2023 · M. Klein, M. DiGuardo, et al. · Transfusion
The long road to TRAIL therapy: a TRAILshort detour
2021 · Aswath P. Chandrasekar, Mark Maynes, et al. · Oncotarget
PDF
Works count: 16
Citation count: 185
H-index: 7
I10-index: 6
Year
Topic
Type